|Bid||67.66 x 800|
|Ask||67.90 x 2200|
|Day's Range||64.61 - 68.82|
|52 Week Range||37.08 - 180.59|
|Beta (5Y Monthly)||2.00|
|PE Ratio (TTM)||N/A|
|Earnings Date||Nov 02, 2022 - Nov 07, 2022|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||124.00|
Subscribe to Yahoo Finance Plus to view Fair Value for NTLA
Celebrations may be in order for Intellia Therapeutics, Inc. ( NASDAQ:NTLA ) shareholders, with the analysts delivering...
Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...
Alnylam stock cooled Friday as one expert argued the company will have to run a second study of its cardiomyopathy drug to gain traction.